COOL — Core One Labs Balance Sheet
0.000.00%
HealthcareSpeculativeMicro Cap
Annual balance sheet for Core One Labs, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.994 | 0.412 | 1.9 | 0.873 | 0.736 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.077 | 0.437 | 3 | 0.214 | 0.184 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 3.87 | 3.75 | 4.99 | 1.16 | 1.13 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 17.2 | 14 | 0.447 | 0.155 | 0.685 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Total Assets | 21.1 | 17.8 | 9.52 | 7.61 | 8.11 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.78 | 8.69 | 3.7 | 3.3 | 1.4 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Liabilities | 3.29 | 10.6 | 4.13 | 3.3 | 1.4 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 17.8 | 7.23 | 5.39 | 4.31 | 6.71 |
| Total Liabilities & Shareholders' Equity | 21.1 | 17.8 | 9.52 | 7.61 | 8.11 |
| Total Common Shares Outstanding |